FDA Recommends Popular IBS Drug Not Be Sold in US - KCBD NewsChannel 11 Lubbock

3/30/07

FDA Recommends Popular IBS Drug Not Be Sold in US

It's been high profile in tv ads, but no more. The Food and Drug Administration says Zelnorm, marketed for irritable bowel syndrome, should not be sold in the U.S.

The maker of Zelnorm has agreed to withdraw Zelnorm from pharmacy shelves. This is because the drug has been linked to a higher risk of stroke, heart attack, or severe chest pain that could turn into a heart attack.  This comes after a review of 29 clinical studies of Zelnorm, which pointed to a small number of patients who developed what could be life-threatening side effects.

Instead of pitching all those pills in the trash, the FDA is recommending doctors help their patients ease off Zelnorm before switching them to some other therapy.

Powered by WorldNow

5600 Avenue A
Lubbock, TX. 79404

FCC Public File
publicfile@kcbd.com
806-744-1414
EEO Report
Closed Captioning

All content © Copyright 2000 - 2014 Worldnow and KCBD. All Rights Reserved.
For more information on this site, please read our Privacy Policy and Terms of Service.